Polymyxin B SulfateThird Party Manufacturing in India

Polymyxin B Sulfate works by binding to phospholipids and lipopolysaccharides (LPS) in the outer membrane of Gram-negative bacteria. This cationic interaction acts like a detergent, disrupting the permeability barrier and structural integrity of the outer and cytoplasmic membranes. The loss of membrane barrier function causes leakage of essential intracellular chemical contents and leads to rapid bacterial cell death. It is highly bactericidal against critical Gram-negative pathogens.

Therapeutic Uses

Polymyxin B Sulfate is indicated for the treatment of severe Gram-negative infections:

• Multidrug-Resistant Infections: Reserved for infections caused by multidrug-resistant Gram-negative bacteria when other agents are ineffective.
• Meningitis: Treats meningeal infections caused by Pseudomonas aeruginosa.
• Urinary Tract Infections: Treatment of severe UTIs caused by susceptible Gram-negative strains.
• Ocular and Topical Infections: Used in ophthalmic and topical preparations for superficial bacterial infections.

Why Manufacturers Choose Polymyxin B Sulfate

Polymyxin B Sulfate is a critical, last-resort antibiotic widely used in hospital intensive care units to combat carbapenem-resistant infections. This clinical necessity maintains constant institutional and emergency procurement demand. Sourcing Polymyxin B Sulfate third party manufacturing in India from WHO-GMP certified sterile powder filling facilities ensures high sterility assurance, precise dosage filling, and compliant packaging.

Indian manufacturers offer excellent manufacturing capacity for Polymyxin B (5 Lac IU injections), allowing international distributors to secure vital ICU supplies at highly competitive rates while maintaining high product quality standards.